KAITLIN GILBERT: Open Payments
NPI 1275943938 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,990 in 137 payments from 20 companies in 2025. Trend: 2023 $2,576 · 2024 $3,717 · 2025 $2,990
Food & beverage: $2,891Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $584 |
| Madrigal Pharmaceuticals | 5 | $366 |
| Gilead Sciences, Inc. | 18 | $360 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $286 |
| Ardelyx, Inc. | 11 | $224 |
| Janssen Biotech, Inc. | 4 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Alexion Pharmaceuticals, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $120 |
| Lundbeck LLC | 1 | $114 |
Products named: REZDIFFRA, RINVOQ, XIFAXAN, IBSRELA, TREMFYA, WAINUA, ENTYVIO, REXULTI.
Industry payments across VA — which companies pay providers there.
